A FIT test (fecal immunochemical test) checks stool for hidden blood. It uses antibodies to detect human hemoglobin, the oxygen-carrying protein in red blood cells. A positive result needs follow-up; a negative result does not rule out every cause of symptoms. [1]
On this page
What do FIT test results mean?
“Occult” means hidden: you may not see blood even when the test detects it. FIT mainly detects bleeding from the lower digestive tract. It cannot locate the bleeding or show what caused it. [1]
| Result | Meaning and next step |
|---|---|
| Positive or above the report cutoff | Blood was detected at a level the assay flags. Contact your clinician about investigating the cause. A positive screening FIT requires follow-up colonoscopy. [4] |
| Negative or below the cutoff | The sample did not meet the test’s positive threshold. Keep your screening schedule and seek assessment for symptoms; some cancers or polyps do not bleed when a sample is taken. [1] |
| A number or “<dl” | Check the units, reference interval and report key. A concentration is not a cancer probability. “<dl” means below the detectable limit in the manufacturer’s sample report. [3] |
Blood may come from hemorrhoids, polyps, inflammation or colorectal cancer, among other causes. A positive FIT therefore does not mean you have cancer. Equally, known hemorrhoids are not a reason to assume the result is harmless. The test itself cannot distinguish these causes. [5]
How the occult-blood marker fits into GI-MAP
GI-MAP includes an Occult Blood – FIT measurement among its intestinal-health markers. This is an antibody-based hemoglobin measurement, separate from the panel’s qPCR analysis of microbial DNA. It does not measure the number of bacteria, and a microbial finding cannot establish why blood is present. [2]
Understanding the GI-MAP reference range
The laboratory’s 2025 sample report lists an occult-blood reference of less than 10 µg/g and an example result of “<dl.” Use the reference and units printed on your report; do not transfer a cutoff between different tests or laboratories. Manufacturer documentation describes this assay, not a universal rule for ruling out cancer. [3]
For example, a result of 5 µg/g is below that sample report’s cutoff. That arithmetic alone cannot tell you whether symptoms need investigation or whether you are up to date with cancer screening. Review the complete report, your history and the reason for testing with your clinician. See our GI-MAP sample-report overview for the other sections.
Does GI-MAP replace a colorectal cancer screening FIT?
Do not assume it does. A broader stool panel containing a blood marker is not automatically equivalent to completing an established colorectal screening pathway. Ask the clinician responsible for your screening whether the specific test and follow-up plan meet your needs.
For U.S. adults at average risk with no symptoms, the USPSTF recommends colorectal cancer screening from ages 45 through 75. Annual FIT is one recommended option; screening from 76 through 85 is individualized. Personal or family history may require a different plan. A positive stool-based screening result needs colonoscopy to achieve the benefit of screening. [4]
Screening looks for disease before symptoms. Visible bleeding, iron-deficiency anemia or persistent bowel changes call for clinical assessment, even if a recent stool result was negative. They should not be managed by repeatedly ordering mail-in panels. [7]
FIT vs. FOBT vs. stool DNA testing
- FOBT is an umbrella term for fecal occult blood testing. FIT is an immunochemical type; guaiac-based FOBT uses a chemical reaction and may have different food or medication instructions. [5]
- Stool DNA–FIT cancer screening combines blood detection with selected DNA changes in cells shed into stool. It is different from testing microbial DNA. [6]
- GI-MAP combines microbial targets with intestinal-health markers. Its occult-blood result does not turn the panel into a stool DNA colorectal cancer screening test. [2]
- Colonoscopy lets a clinician examine the colon and remove some polyps. A stool test cannot do either. [6]
How is a FIT sample collected?
A standalone FIT usually uses a small stool sample collected at home, without a bowel-cleansing preparation. Follow the exact kit instructions for collection, labeling and return timing. FIT instructions should not be substituted for GI-MAP collection instructions, or vice versa. Do not change prescribed medicines without asking your clinician. [1]
When symptoms need prompt attention
Seek medical help promptly for black, tarry stool or visible rectal bleeding. Heavy bleeding, fainting, severe dizziness, shortness of breath or vomiting blood can signal an emergency. Call emergency services if you are severely unwell. Do not wait for a stool-test result to decide whether significant bleeding needs care. [7]
Common questions
Can a FIT test be positive without cancer?
Yes. Blood can have several causes. “Positive” describes the test finding, not a diagnosis. Your clinician can arrange the appropriate investigation; do not attribute it to hemorrhoids without assessment. [5]
Can I repeat a positive FIT instead of having a colonoscopy?
A later negative sample does not undo an earlier positive screening result: bleeding can vary. Discuss the recommended colonoscopy and any concerns with your clinician instead of using a repeat test to cancel follow-up. [4]
Is a negative FIT an all-clear for bowel cancer?
No. A lesion may not bleed at the time of collection. Continue the screening schedule agreed with your clinician, and report symptoms regardless of the result. [1]
Does normal calprotectin explain away a positive FIT?
No. Calprotectin is a separate inflammation marker. The two measurements answer different questions; one normal marker does not identify or dismiss the source of blood. [2]
Sources and review
Sources checked October 22, 2026. Manufacturer sources establish assay details; public clinical guidance supports screening and follow-up statements.
- MedlinePlus: Fecal immunochemical test (reviewed July 2025)
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (2025; manufacturer)
- Diagnostic Solutions Laboratory: GI-MAP with StoolOMX sample report (2025), page 4
- USPSTF: Colorectal cancer screening recommendation
- MedlinePlus: Fecal occult blood test (FOBT)
- National Cancer Institute: Colorectal cancer screening
- NIDDK: Symptoms and causes of gastrointestinal bleeding
This article has been reviewed by Madison Ordway, FDN-P. For a correction or source question, contact Gi Map Test.